NOT, TARCISIO
 Distribuzione geografica
Continente #
NA - Nord America 19.755
AS - Asia 8.910
EU - Europa 8.574
SA - Sud America 1.141
AF - Africa 156
Continente sconosciuto - Info sul continente non disponibili 40
OC - Oceania 22
Totale 38.598
Nazione #
US - Stati Uniti d'America 19.581
SG - Singapore 3.140
CN - Cina 2.085
PL - Polonia 1.439
UA - Ucraina 1.376
IT - Italia 1.304
SE - Svezia 1.263
VN - Vietnam 902
BR - Brasile 895
HK - Hong Kong 847
KR - Corea 674
DE - Germania 544
FI - Finlandia 542
FR - Francia 515
TR - Turchia 455
GB - Regno Unito 385
RU - Federazione Russa 318
BD - Bangladesh 271
IE - Irlanda 243
BG - Bulgaria 229
IN - India 155
NL - Olanda 107
AR - Argentina 97
CA - Canada 84
ES - Italia 65
IQ - Iraq 54
MX - Messico 49
MA - Marocco 46
ID - Indonesia 44
JP - Giappone 44
EU - Europa 36
EC - Ecuador 31
BE - Belgio 30
PK - Pakistan 30
VE - Venezuela 30
AT - Austria 28
ZA - Sudafrica 28
CH - Svizzera 27
CL - Cile 26
RO - Romania 24
CO - Colombia 22
PH - Filippine 20
SA - Arabia Saudita 20
EG - Egitto 18
CZ - Repubblica Ceca 17
IR - Iran 17
KE - Kenya 17
PT - Portogallo 17
UZ - Uzbekistan 17
AU - Australia 16
PY - Paraguay 15
MT - Malta 14
IL - Israele 13
JO - Giordania 12
TH - Thailandia 12
DK - Danimarca 11
DZ - Algeria 11
LT - Lituania 11
PE - Perù 11
SN - Senegal 11
AZ - Azerbaigian 10
HR - Croazia 10
HU - Ungheria 9
MY - Malesia 9
NP - Nepal 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
CR - Costa Rica 8
KZ - Kazakistan 8
BA - Bosnia-Erzegovina 7
JM - Giamaica 7
KG - Kirghizistan 7
LB - Libano 7
AM - Armenia 6
LV - Lettonia 6
OM - Oman 6
BO - Bolivia 5
DO - Repubblica Dominicana 5
GR - Grecia 5
LK - Sri Lanka 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AL - Albania 4
BY - Bielorussia 4
CI - Costa d'Avorio 4
EE - Estonia 4
HN - Honduras 4
MN - Mongolia 4
PA - Panama 4
A2 - ???statistics.table.value.countryCode.A2??? 3
GT - Guatemala 3
KW - Kuwait 3
LY - Libia 3
PS - Palestinian Territory 3
QA - Qatar 3
SI - Slovenia 3
BH - Bahrain 2
CY - Cipro 2
Totale 38.564
Città #
Woodbridge 2.131
Ann Arbor 1.847
Fairfield 1.788
Singapore 1.774
Houston 1.681
Ashburn 1.663
Jacksonville 1.208
Warsaw 1.178
Chandler 988
San Jose 890
Wilmington 877
Hong Kong 812
Seattle 778
Seoul 664
Cambridge 610
Hefei 585
Beijing 461
Princeton 448
Boardman 414
Izmir 381
Chicago 288
Ho Chi Minh City 253
Dublin 243
Columbus 227
Lauterbourg 222
Sofia 222
Trieste 218
Zgierz 216
Dallas 215
Hanoi 214
Los Angeles 205
Milan 177
The Dalles 175
Moscow 174
Buffalo 173
Düsseldorf 131
Dearborn 120
Frankfurt am Main 109
Helsinki 104
Santa Clara 102
São Paulo 93
San Diego 90
Munich 89
Bremen 82
Council Bluffs 78
New York 78
London 68
Verona 61
Da Nang 51
Memphis 51
Guangzhou 49
Haiphong 44
Turku 38
Nanjing 37
Des Moines 36
Tianjin 36
Jinan 35
Sacile 35
Tokyo 35
Casablanca 34
Orem 30
Toronto 30
Atlanta 29
Brussels 28
Chennai 28
Shanghai 28
Kunming 27
Phoenix 26
Rome 26
Falls Church 25
Nuremberg 25
Hangzhou 24
Mestre 24
Brooklyn 23
Fremont 23
Redondo Beach 23
Dong Ket 22
Washington 22
Montreal 21
Norwalk 21
Ankara 20
Poplar 20
Rio de Janeiro 20
Baghdad 19
Miano 19
San Francisco 19
Brasília 18
Curitiba 18
Philadelphia 18
Pune 18
Stockholm 18
Bern 17
Boston 17
Tashkent 17
Wroclaw 17
Barnet 16
Biên Hòa 16
Campinas 16
Dhaka 16
Mumbai 16
Totale 26.946
Nome #
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 493
Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy 381
Cross-sectional study of coeliac autoimmunity in a population of Vietnamese children 356
Combined Analysis of Methylation and Gene Expression Profiles in Separate Compartments of Small Bowel Mucosa Identified Celiac Disease Patients’ Signatures 348
Changing Epidemiology of Liver Involvement in Children with Celiac Disease 347
Electrochemical Immunosensor Based on Nanoelectrode Ensembles for the Serological Analysis of IgG-type Tissue Transglutaminase 337
Ghrelin Derangements in Idiopathic Dilated Cardiomyopathy: Impact of Myocardial Disease Duration and Left Ventricular Ejection Fraction 333
Anti-transglutaminase antibodies and age. 303
Anti transglutaminase antibodies cause ataxia in mice. 302
Anti-transglutaminase 6 antibody development in children with celiac disease correlates with duration of gluten exposure 301
A reliable screening procedure for coeliac disease in clinical practice. 300
A novel quantitative ELISA as accurate and reproducible tool to detect epidermal transglutaminase antibodies in patients with Dermatitis Herpetiformis 299
One-step cloning of anti tissue transglutaminase scFv from subjects with celiac disease. 297
Diagnostic accuracy and applicability of intestinal auto-antibodies in the wide clinical spectrum of coeliac disease 295
Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. 292
Galectin 3 and Galectin 3 Binding Protein Improve the Risk Stratification after Myocardial Infarction 292
Analyzing the peripheral blood antibody repertoire of a celiac disease patient using phage antibody libraries 290
Coeliac disease in the ERA of the new ESPGHAN and BSPGHAN guidelines: a prospective cohort study 290
Intestinal production of anti-tissue transglutaminase 2 antibodies in patients with diagnosis other than celiac disease 288
Testing for Anti-Human Transglutaminase Antibodies in Saliva Is Not Useful for Diagnosis of Celiac Disease 287
Diagnostic Delays in Children with Coeliac Disease in the Central European Region 268
Immunohistologic analysis of the duodenal bulb: a new method for celiac disease diagnosis in children 264
Variant mannose-binding lectin alleles are associated with celiac disease 261
Serum Anti-Tissue Transglutaminase Antibodies Detected during Febrile Illness May Not Be Produced by the Intestinal Mucosa 257
Potential use of MCR-ALS for the identification of coeliac-related biochemical changes in hyperspectral Raman maps from pediatric intestinal biopsies 255
Tag-single nucleotide polymorphism-based human leukocyte antigen genotyping in celiac disease patients from northeastern Italy 254
Looking for celiac disease: diagnostic accuracy of two rapid commercial assays 253
The analysis of the fine specificity of celiac disease antibodies using tissue transglutaminase fragments 250
Innate and adaptive immunity in self-reported nonceliac gluten sensitivity versus celiac disease 249
The humoral response in the pathogenesis of gluten ataxia 245
Autoantibodies as predictors of disease. 241
The Use of Biopsy and "no-Biopsy" Approach for Diagnosing Paediatric Coeliac Disease in the Central European Region 239
Clinical Presentation in Children With Coeliac Disease in Central Europe 238
Dual sugar gut-permeability testing on blood drop in animal models. 236
Regulatory T-Cell Function Is Impaired in Celiac Disease. 234
The gut as site of production of autoimmune antibodies. 233
A Sensitive Electrochemiluminescence Immunosensor for Celiac Disease Diagnosis Based on Nanoelectrode Ensembles 233
A Functional Idiotype/Anti-Idiotype Network Is Active in Genetically Gluten-Intolerant Individuals Negative for Both Celiac Disease-Related Intestinal Damage and Serum Autoantibodies 233
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. 229
Prevalence of celiac disease in patients with severe food allergy 228
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency. 222
Anti-transglutaminase and age, Clinical Chemestry 221
Molecular dissection of the tissue transglutaminase auto-antibody response in celiac disease 221
Sedation with intranasal midazolam of Angolan children undergoing invasive procedures. 221
Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations 220
The shared CTLA4-ICOS risk locus in celiac disease, IgA deficiency and common variable immunodeficiency 219
Evaluation of gut-vascular barrier by plasmalemma vesicle-associated protein-1 measurements in patients with celiac disease and abnormal serum alanine transaminase 217
Ages of celiac disease: from changing environment to improved diagnostics 216
Anti-idiotypic response in mice expressing human autoantibodies. 215
Association study of the IL18RAP locus in three European populations with coeliac disease 215
Anti-alpha enolase autoantibodies in coeliac disease 213
Anti tTG autoantibodies crossreacting with brain structures are produced in the intestine in celiac patient with equilibrium disorder 212
Anti-brain but not celiac disease antibodies in Landau-Kleffner Syndrome and related epilepsies. 211
A population based seroepidemiological survey of Chlamydia pneumoniaeinfections in schoolchildren. 209
Anti-α-enolase Antibodies in Serum from Pediatric Patients Affected by Inflammatory Diseases: Diagnostic and Pathogenetic Insights. 208
Antibodies against breain structures in a celiac patient with ataxic syndrome are produced in the intestine 207
Speeding up coeliac disease diagnosis in cardiological settings 207
Celiac Disease Frequency Is Increased in IgE-Mediated Food Allergy and Could Affect Allergy Severity and Resolution 206
Development of a novel rapid non-invasive screening test for coeliac disease. 204
Antibodies to transglutaminasefrom phage display libraries 204
Alterations in zonulinsecretion precedes the onset of diabetes in BB/Wor rats 202
Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ. 200
Digital Radiology to Improve the Quality of Care in Countries with Limited Resources: A Feasibility Study from Angola 197
A new, rapid, noninvasive screening test for celiac disease. 195
A zonulin-occludens toxin synthetic esapeptide modifies the intestinal permeabilità in in-vivo animal model 195
Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease 192
Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases 192
Zonulin is involved in the impairment of the gut barrier function following small intestinal bacterial colonization 192
Human recombinant tissue transglutaminase ELISA: an innovative diagnostic assay for celiac disease. 192
Humoral response in the pathogenesis of gluten ataxia 191
Sensitivity and specificity of simple and rapid commercial assays for the diagnosis of coeliac disease 190
Gastrointestinal Foxp3 expression in normal, inflammatory and neoplastic conditions 188
Management of coeliac disease patients after the confirmation of diagnosis in Central Europe 188
Celiac disease in patients with sporadic and inherited cardiomyopathies and in their relatives. 186
Abdominal presentation ofcat acratch disease: is a biopsy always necessary? 185
Strip AGA test: a rapid and accurate method in screening for coeliac disease 184
Protective role of anti-idiotypic network in celiac disease prone subjects 182
Compliance with the gluten-free diet: the role of locus of control in celiac disease 181
Search for atoxic cereals: a single blind, cross-over study on the safety of a single dose of Triticum monococcum, in patients with celiac disease. 180
The microsnapwell system: a new in vitro polarized model for studying the intestinal barrier functions using small intestinal biopsy specimens 179
Alterations in zonulin secretion parallels changes in intestinal permeability and precede the onset of diabetes in BB/Wor diabetic rats 178
Charecterization of tissue transglutaminase auto-antigenic response using cloned structural domains 178
Mucosal tissue transglutaminase expression in celiac disease 178
Cloning and characyerization of intestinal antibodies to tissue transglutaminase in celiac disease patients 177
Serological Proteome Analysis (SERPA) as a tool for the identification of new candidate autoantigens in type 1 diabetes. 177
Mass screening for coeliac disease using antihuman transglutaminase antibody assay. 174
Prevalence of celiac disease among risk groups and the general population in USA 174
Gluten dependent diabetes-related and thyroid-related autoantibodies in coeliac patients: a prospective study. 173
Profiling celiac disease antibody repertoire 172
Role of zonulin in the intestinal permeability changes typical of the acute phase of coeliac disease 171
Site of syntesis of antibodies to A-gliadin and tissue-transglutaminase in celiac disease patients 171
Screening ofcoeliac disease in helthy blood donors from two immunotransfusionalcenters in nothest Italy 170
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal mucosa anti-transglutaminase antibodies 170
Protective role of anti-idiotypic network in celiac disease prone subjects 169
Autoinflammatory syndromes and coeliac disease: One observation and two hypotheses 169
Spectroscopic investigation of faeces with surface-enhanced Raman scattering: a case study with coeliac patients on gluten-free diet 169
Usefulness of gluten-free diet in gluten-genetically predisposed subjects positive to intestinal-mucosa anti-transglutaminase antibodies 168
Rapid Genetic Screening for major HLA risk haplotypes in patients with type 1 diabetes from North East Brazil 168
Alterations in zonulin secretion accompany the increase in permeability in BB/Wor rats 167
Coeliac disease in primary care: evaluation of a case-finding strategy 165
Totale 22.828
Categoria #
all - tutte 111.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021328 0 0 0 0 0 0 0 0 0 0 0 328
2021/20222.367 108 198 110 269 84 181 95 84 296 233 217 492
2022/20233.145 361 379 234 396 362 561 16 269 377 19 108 63
2023/20241.818 114 120 80 118 199 139 314 351 41 33 147 162
2024/20253.986 43 163 293 391 423 345 305 215 528 425 354 501
2025/202611.048 808 667 1.059 1.070 872 1.108 1.496 437 1.197 1.458 567 309
Totale 39.086